Literature DB >> 14695941

The protective and healing effects of a natural antioxidant formulation based on ubiquinol and Aloe vera against dextran sulfate-induced ulcerative colitis in rats.

Ludmila Korkina1, Maxim Suprun, Anna Petrova, Elena Mikhal'chik, Antonio Luci, Chiara De Luca.   

Abstract

Oxygen/nitrogen reactive species (ROS/RNS) are currently implicated in the pathogenesis of ulcerative colitis, drawing attention on the potential prophylactic and healing properties of antioxidants, scavengers, chelators. We evaluated the possible protective/curative effects of a natural antioxidant preparation based on Aloe vera and ubiquinol, against intestinal inflammation, lesions, and pathological alterations of the intestinal electrophysiological activity and motility, in a rat model of DSS-induced colitis. 5% dextrane sulfate (DDS) (3 days), followed by 1% DSS (4 days) was administered in drinking water. The antioxidant formulation (25 mg/kg) was delivered with a pre-treatment protocol, or simultaneously or post-colitis induction. Spontaneous and acetylcholine-stimulated electrical activity were impaired in the small intestine and in distal colon, upon exposure to DSS only. Severe inflammation occurred, with increased myeloperoxidase activity, and significant alterations of the oxidant/antioxidant status in colonic tissue and peritoneal cells. Lipoperoxidation, superoxide production, glutathione peroxidase and glutathione-S-transferase activities, and reduced glutathione content increased, whilst superoxide dismutase and catalase activities were sharply suppressed in colon tissue. ROS/RNS formation in peritoneal cells was strongly inhibited. Inflammation, electrical/mechanical impairment in the gut, and a great majority of oxidative stress parameters were improved substantially by pre-treatment with the antioxidant preparation, but not by simultaneous administration or post-treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14695941     DOI: 10.1002/biof.5520180228

Source DB:  PubMed          Journal:  Biofactors        ISSN: 0951-6433            Impact factor:   6.113


  8 in total

1.  Hyperhomocysteinemia decreases intestinal motility leading to constipation.

Authors:  S Givvimani; C Munjal; N Narayanan; F Aqil; G Tyagi; N Metreveli; S C Tyagi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-05-17       Impact factor: 4.052

2.  Impact of basal diet on dextran sodium sulphate (DSS)-induced colitis in rats.

Authors:  Ahlem Boussenna; Nicolas Goncalves-Mendes; Juliette Joubert-Zakeyh; Bruno Pereira; Didier Fraisse; Marie-Paule Vasson; Odile Texier; Catherine Felgines
Journal:  Eur J Nutr       Date:  2014-11-20       Impact factor: 5.614

3.  Plasma, tissue and urinary levels of aloin in rats after the administration of pure aloin.

Authors:  Mi-Young Park; Hoon-Jeong Kwon; Mi-Kyung Sung
Journal:  Nutr Res Pract       Date:  2008-03-31       Impact factor: 1.926

Review 4.  Nitric oxide as a target of complementary and alternative medicines to prevent and treat inflammation and cancer.

Authors:  Lorne J Hofseth
Journal:  Cancer Lett       Date:  2008-04-25       Impact factor: 8.679

5.  Changes in Serum Electrolytes, Urea, and Creatinine in Aloe Vera-treated Rats.

Authors:  Wa Saka; Re Akhigbe; Ot Popoola; Os Oyekunle
Journal:  J Young Pharm       Date:  2012-04

6.  Intestinal absorption of aloin, aloe-emodin, and aloesin; A comparative study using two in vitro absorption models.

Authors:  Mi-Young Park; Hoon-Jeong Kwon; Mi-Kyung Sung
Journal:  Nutr Res Pract       Date:  2009-03-31       Impact factor: 1.926

7.  Plant-derived polysaccharide supplements inhibit dextran sulfate sodium-induced colitis in the rat.

Authors:  Lee Koetzner; Gary Grover; Jamie Boulet; Henry I Jacoby
Journal:  Dig Dis Sci       Date:  2009-06-10       Impact factor: 3.199

8.  Intestinal inflammation in rats induces metallothionein in colonic submucosa.

Authors:  Yasmin Al-Gindan; Mohammed Shawarby; Amy Noto; Carla G Taylor
Journal:  J Clin Biochem Nutr       Date:  2009-02-28       Impact factor: 3.114

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.